-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bt8XlqTPpRPzBbUftNG1ATXUYumNbdcqiXWEOaWNzl/QXqW5D3EaY0kxi5b+b4Ev OaJR0M9LQ2LUY0HuCbkIdA== /in/edgar/work/20000818/0000069499-00-000026/0000069499-00-000026.txt : 20000922 0000069499-00-000026.hdr.sgml : 20000922 ACCESSION NUMBER: 0000069499-00-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000601 FILED AS OF DATE: 20000818 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN LABORATORIES INC CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 001-09114 FILM NUMBER: 705977 BUSINESS ADDRESS: STREET 1: 130 SEVENTH ST STREET 2: 1030 CENTURY BLDG CITY: PITTSBURGH STATE: PA ZIP: 15222 BUSINESS PHONE: 4122320100 MAIL ADDRESS: STREET 1: 1030 CENTURY BUILDING STREET 2: 130 SEVENTH STREET CITY: PITTSBURGH STATE: PA ZIP: 15222 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 COMPANY DATA: COMPANY CONFORMED NAME: BARNETT DANA CENTRAL INDEX KEY: 0001115066 STANDARD INDUSTRIAL CLASSIFICATION: [ ]DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O SOMERSET PHARACEUTICALS STREET 2: 2202 N WEST SHORE BLVD - STE 450 CITY: TAMPA STATE: FL ZIP: 33607 MAIL ADDRESS: STREET 1: 318 FOURTH AVENUE NORTH CITY: TIERRA VERDE STATE: FL ZIP: 33715 4 1 0001.txt
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 4 Washington, D. C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ( ) Check here if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). - ------------------------------------------------------------------------------------------------------------------------------------ |1 Name and Address of Reporting Person * |2 Issuer Name and Ticker/Trading Symbol|6 Relationship of Reporting | | | | Person(s) to Issuer | | Barnett Dana G |Mylan laboratories Inc. MYL | (Check All Applicable) | | |---------------------------------------| ( X ) Director ( ) 10% Owner | | (Last) (First) (Middle) |3 IRS Identifica-|4 Statement for | ( X ) Officer ( ) Other | | | tion Number of | Month/Year | (Give Title below) (Specify below) | | 318 4th Avenue N. | Reporting | | | | (Street 1) | Person, if | 10/01/2000 | Executive Vice President | | | an entity |---------------------|------------------------------------| | | (Voluntary) |5 If Amendment, |7 Individual or Joint/Group Filing | | (Street 2) | | Date of Original | (Check Applicable) | | | ###-##-#### | (Month/Year) | Form filed by: | | Tierra Verde FL 33715 | | 06/01/00 | (X) One Reporting Person | | (City) (State) (Zip) | | | ( ) One Reporting Person | - ------------------------------------------------------------------------------------------------------------------------------------ Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ |1 Title of Security |2 Trans- |3 Trans- |4 Securities Acquired |5 Amount of |6 Ownership|7 Nature of Indirect | | (Instruction 3) | action | action | (A) or Disposed of (D) | Securities | Form: | Beneficial Ownership | | | Date | Code | (Instructions 3, 4, 5) | Beneficially | Direct(D) | (Instruction 4) | | | (Month/ | (Instr 8)|------------------------| Owned at | or | | | | Day) |----------| Amount |(A)| Price | End of Month |Indirect(I)| | | | Year) | Code | V | |(D)| |(Instrs 3, 4) | (Instr 4) | | |--------------------------------|---------|------|---|-----------|---|--------|--------------|-----------|------------------------| |Mylan Laboratories Inc. | 06/14/00| P | | 10,000 | A | $17.75 | 85,972 | | | |Common Stock | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 1474 (3-99)
FORM 4 (Continued) - ------------------------------------------------------------------------------------------------------------------------------------ Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (Puts, Calls, Warrants, Options, Convertible Securities) - ------------------------------------------------------------------------------------------------------------------------------------ |1 Title of |2 Con- |3 Trans-|4 Trans-|5 Number of |6 Date |7 Title and Amount|8 Price |9 Number|10 Own-|11 Nature| | Derivative | version| action | action | Derivative | Exercisable and | of Underlying | of |of Deri-|ership:| of | | Security | or | Date | Code | Securities | Expiration Date | Securities | Deri- |vative |Direct |Indirect | | (Instr 3) | Exer- | (Month/| (Instr | Acquired (A) or | (Month/Day/Year)|(Instructions 3,4)| vative |Securi- |(D) or |Ownership| | | cise | Day/ | 8) | Disposed of (D) |-----------------|------------------| Sec- |ties |Indi- |(Instr 4)| | | Price | Year) | |(Instrs 3, 4, 5) | Date | Expir- | |Amount | urity |Owned at|rect(I)| | | | | |--------|-----------------| Exer- | ation | Title |or Num- |(Instr |End of |(Instr | | | | | |Code| V | (A) | (D) | cisable| Date | |ber of | 5) |Month | 4) | | | | | | | | | | | | |Shares | |(Instr4)| | | |------------|--------|--------|----|---|--------|--------|--------|--------|---------|--------|--------|--------|-------|---------| | NONE | | | | | | | | | | 230,000| D | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: Reporter has the "right to buy" 230,000 shares pursuant to the Issuers Stock Option Plan at exercise prices ranging from $12.00 to $17.75 Dana G Barnett Jul 5, 2000 ____________________________________________ ____________ ** Signature of Reporting Person Date ** Intentional misstatement or ommissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: Transmit one copy of this Form to EDGAR, using a typed signature. If space is insufficient, see Intruction 6 for procedure. SEC 1474 (3-99)
-----END PRIVACY-ENHANCED MESSAGE-----